Advanced BioDesign is a pre-clinical stage biotechnology company founded in 2010 and focused on the development of novel anticancer drugs, focusing specifically on targeting ALDH as therapeutic approach for acute myeloid leukaemia and other cancers with high unmet medical needs.
Our innovative strategy aims to overcome tumour chemoresistance and to restore or activate endogenous cell death mechanisms in cancer cells.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.